- $8.58bn
- $10.18bn
- $4.17bn
- 78
- 43
- 74
- 70
2019 December 31st | 2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,123 | 2,982 | 2,800 | 3,836 | 4,174 |
Cost of Revenue | |||||
Gross Profit | 638 | 293 | 333 | 714 | 826 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 3,791 | 4,309 | 2,734 | 3,548 | 3,707 |
Operating Profit | 331 | -1,327 | 65.9 | 289 | 466 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 242 | -1,482 | 233 | 355 | 295 |
Provision for Income Taxes | |||||
Net Income After Taxes | 270 | -1,560 | 207 | 339 | 423 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 258 | -1,573 | 185 | 324 | 411 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 270 | -1,573 | 201 | 337 | 421 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.62 | -5.17 | 1.46 | 3.19 | 3.18 |